Search the Archive

Glaucoma / New Drug Treatment #259770

CBS Evening News for Thursday, Sep 28, 1978
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio) Often unpleasant side effects of drugs used to treat glaucoma noted.
REPORTER: Walter Cronkite

(NYC) [Glaucoma patient Judy SCHWEID- was scared at first; didn't know what effect disease would have on her.] Details about glaucoma given. Announcement in New York City that FDA (Food and Drug Administration) has approved new glaucoma treatment drug reported; description of drug given. Has been in use in Europe for several years [New York Med. College spokesperson Dr. Miles GALIN - outlines advantages of drug.] [SCHWEID-says treatment has been wonderful.]
REPORTER: Charles Crawford

Reporter(s):
Crawford, Charles;
Cronkite, Walter
Duration:
00:02:10

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.